CKD: A Call for an Age-Adapted Definition
Pierre Delanaye(University of Liège), Jan A.J.G. van den Brand(University Hospital of Bern), Markus van der Giet(Charité - Universitätsmedizin Berlin), Toralf Melsom(University Hospital of North Norway), Andrew D. Rule(Mayo Clinic), Elke Schäeffner, Giovanni Gambaro(University of Verona), Kitty J. Jager(Amsterdam University Medical Centers), Anders Grubb(Lund University), Runólfur Pálsson(Reykjavík University), Laurence Dubourg(Lyon 1 Université), Marco van Londen(University Medical Center Groningen), Arend Bökenkamp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gunnar Nordin, Hans Pottel(University of Liège), Richard J. Glassock(University of California, Los Angeles), Christine A. White(Queen's University), F. Gaillard(Hôpital Européen Georges-Pompidou), Olivier Moranne(US Forest Service), Ólafur S. Indridason(Reykjavík University), Björn O. Eriksen(University Hospital of North Norway), Anders Christensson(Lund University), Christophe Mariat(Hôpital Nord), Maarten W. Taal(University of Nottingham)
Cited by 358
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808